U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

As you can see from the chart above the percentage of shares that are sold short for Vertex Pharmaceuticals has grown since its last report. This does not mean that the stock is going to fall in ...

Vertex Pharmaceuticals (VRTX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's ...

Vertex Pharmaceuticals VRTX has outperformed ... it would be worth $330.01 today based on a price of $411.66 for VRTX at the time of writing. Finally -- what's the point of all this?

The new year is here, and the race for top jobs is already heating up. According to a recent survey, Monday, January 13, was the most popular day of the year to submit resumes nationwide.

BOSTON, January 12, 2025--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced multiple program updates ahead of upcoming investor meetings in January, including the ...

Vertex Pharmaceuticals is hoping to build upon its existing rare blood disease treatment portfolio, teaming up with Orna Therapeutics’ ReNAgade in efforts to develop next-gen gene therapies for ...